Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo
Phase of Trial: Phase II
Latest Information Update: 28 Oct 2014
Price : $35 *
At a glance
- Drugs Aprepitant (Primary)
- Indications Prurigo; Prurigo nodularis
- Focus Therapeutic Use
- Acronyms iTAPP
- Sponsors LEO Pharma
- 06 Oct 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 13 Nov 2013 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.
- 06 Nov 2013 New trial record